Page 3 - Derek Exner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A clinical trial examining the efficacy of two devices to monitor and detect atrial fibrillation (AF), or an irregular heartbeat, in ischemic stroke patients--one an implantable device that monitors over 12 months, the other an external device that monitors over a 30-day period--found the implantable device is more than three times more effective in detecting AF, and both are a significant improvement over the current standard of care in Alberta, Canada.

 E-Mail IMAGE: An implantable device that monitors for atrial fibrillation over 12 months is more than three times more effective at detecting the condition than standard care, and could help prevent disabling... view more  Credit: Supplied A clinical trial examining the efficacy of two devices to monitor and detect atrial fibrillation (AF), or an irregular heartbeat, in ischemic stroke patients--one an implantable device that monitors over 12 months, the other an external device that monitors over a 30-day period--found the implantable device is more than three times more effective i...

Alberta Innovates support also benefits patients and the health-care system

Alberta Innovates support also benefits patients and the health-care system Author Share this article Colourbox The innovation pathway is complicated, and increasingly so within the life sciences industry. Companies are faced with challenges navigating product development, market fit, regulatory compliance and business readiness. Through the Health Innovation Platform Partnerships (HIPP), Alberta Innovates has supported four new University of Calgary initiatives focused on building digital health-related products and services to help clients across Alberta and beyond. “At Alberta Inno...